Currently approved for the treatment of vulvovaginal candidiasis, and if the sNDA is approved, ibrexafungerp would be the first and only oral non-azole medication for the prevention of recurrent VVC.
Morgan Ebert, Managing Editor
Advertisement
Morgan Ebert is managing editor of Contemporary OB/GYN® and Contemporary Pediatrics® and joined the MJH Life Sciences team in December 2019. She graduated from Youngstown State University in 2019 with a bachelor's degree in journalism and a minor in political science. Prior to graduating, Morgan worked as the editor-in-chief of her college newspaper. She went on to work as an assignment editor at a broadcast news station in Youngstown, Ohio before joining the Contemporary brands. You can reach her at mpetronelli@mjhlifesciences.com.
Articles by Morgan Ebert, Managing Editor
A presentation at the 2022 American College of Obstetricians and Gynecologists’ Annual Clinical & Scientific Meeting discussed the recent updates in contraceptives including new nonhormonal intrauterine devices.
An interview with Adelaide Hebert, MD, how environmental factors may play a role in flare ups.
The US Food and Drug Administration has approved halobetasol propionate foam, 0.05%, a potent topical corticosteroid, for the treatment of plaque psoriasis in adolescent patients.
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
ACIP votes to update hepatitis B vaccine recommendation for infants
2
New analysis highlights nirsevimab as most impactful RSV prevention strategy for infants
3
Repeal of nonmedical exemptions linked to rise in kindergarten vaccination rates
4
Christine Eng, MD, on addressing barriers to exome and genome sequencing in clinical practice
5
